The ₹2,497.92 crore initial public offering (IPO) of Inventurus Knowledge Solutions (IKS Health) is entering its final subscription day with robust demand across investor categories. Entirely an offer-for-sale (OFS) of 1.88 crore shares, the IPO has been subscribed 7.21 times as of December 16, 2024.
Key IPO Details
- Subscription Period: December 12–16, 2024.
- Price Band: ₹1,265–₹1,329 per share.
- Lot Size: 11 shares (minimum investment ₹14,619).
- Anchor Investor Funds Raised: ₹1,120.18 crore on December 11, 2024.
- Listing Date: Tentatively December 19, 2024.
Subscription Performance
Despite a slow start, the IPO witnessed a surge in demand, particularly from non-institutional and retail investors:
- Qualified Institutional Buyers (QIBs): Subscribed 4.47 times, with bids for 2.51 crore shares against 56.19 lakh shares available.
- Non-Institutional Investors (NIIs): Subscribed 11.77 times, with bids for 3.31 crore shares against 28.09 lakh shares reserved.
- Retail Investors: Subscribed 8.69 times, with bids for 1.63 crore shares against 18.73 lakh shares allocated.
Overall, the IPO saw 7.47 crore bids against the 1.03 crore shares on offer, reflecting strong investor interest as it entered its final day.
Promoters and Post-IPO Shareholding
The company, founded in 2006, is promoted by notable individuals and trusts, including Sachin Gupta, Rekha Jhunjhunwala, and discretionary trusts of Aryaman, Aryavir, and Nishtha Jhunjhunwala. Following the IPO, the promoter group’s stake will reduce from 69.73% to 60.61%.
About Inventurus Knowledge Solutions
Inventurus Knowledge Solutions specializes in administrative services for the healthcare industry. It provides support such as medical scribing, clinical documentation management, and assistance in outpatient and inpatient care.
With a strong focus on operational efficiency, the company simplifies the paperwork burden for medical professionals and healthcare organizations.
Financial Snapshot
For the quarter ending September 30, 2024, the company reported:
- Revenue: ₹1,294 crore.
- Net Profit: ₹208.58 crore.
Anchor Investor Participation
On December 11, 2024, the company raised ₹1,120.18 crore from anchor investors. Half of these shares will remain locked in for 30 days, while the other half will have a lock-in period of 90 days.
